NuVasive Investor Relations

NuVasive is a world leader in minimally invasive, procedurally integrated spine solutions. From complex spinal deformity to degenerative spinal conditions, NuVasive is transforming spine surgery with innovative technologies designed to deliver reproducible and clinically proven surgical outcomes.

Press Releases

September 23, 2021

Summary Toggle NuVasive Opens East Coast Experience Center in New York Metropolitan Area
September 22, 2021

Summary Toggle NuVasive Partners with Scoliosis Research Society in Ongoing Double Diamond Sponsorship
September 09, 2021

Summary Toggle NuVasive Simplify Cervical Disc Data Published In International Journal Of Spine Surgery
September 01, 2021

Summary Toggle NuVasive Announces New Executive Leadership Roles
August 30, 2021

Summary Toggle NuVasive to Present at Upcoming Investor Conference
August 09, 2021

Summary Toggle Amy Belt Raimundo to Join NuVasive Board of Directors
July 30, 2021

Summary Toggle NuVasive Receives Latest FDA 510(k) Clearance for Pulse Platform and Announces Commercial Launch
July 28, 2021

Summary Toggle NuVasive Announces Second Quarter 2021 Financial Results
July 22, 2021

Summary Toggle NuVasive Launches Modulus ALIF 3D-Printed Porous Titanium Implant for Anterior Spine Surgery
July 14, 2021

Summary Toggle NuVasive Announces Conference Call and Webcast of Second Quarter 2021 Results
June 30, 2021

Summary Toggle NuVasive Receives Latest CE Mark Approval for Pulse Platform and Starts Global Clinical Evaluations
May 19, 2021

Summary Toggle NuVasive Appoints Daniel J. Wolterman as Independent Board Chair
May 10, 2021

Summary Toggle NuVasive Appoints Juliet C. Cunningham as Vice President of Investor Relations
May 05, 2021

Summary Toggle NuVasive Announces First Quarter 2021 Financial Results
May 03, 2021

Summary Toggle NuVasive to Present at Upcoming Investor Conferences
April 19, 2021

Summary Toggle NuVasive Announces Conference Call and Webcast of First Quarter 2021 Results
April 06, 2021

Summary Toggle NuVasive's Simplify Disc Receives FDA Approval for Two-Level Cervical Total Disc Replacement
March 25, 2021

Summary Toggle NuVasive Announces Retirement of Gregory T. Lucier from Board of Directors
March 16, 2021

Summary Toggle NuVasive and the International Spine Study Group Foundation Announce Expanded Long-Term Partnership with Initiation of Additional Clinical Studies
February 25, 2021

Summary Toggle NuVasive Announces Fourth Quarter and Full Year 2020 Financial Results
February 24, 2021

Summary Toggle NuVasive Acquires Simplify Medical
February 18, 2021

Summary Toggle NuVasive to Present at the 41st Annual Cowen Health Care Conference
February 11, 2021

Summary Toggle NuVasive Announces Conference Call and Webcast of Fourth Quarter and Full Year 2020 Results
February 08, 2021

Summary Toggle NuVasive Expands Clinical Professional Development Program with New East Coast Experience Center in New York Metropolitan Area
February 01, 2021

Summary Toggle Dr. Siddhartha Kadia to Join NuVasive Board of Directors
January 07, 2021

Summary Toggle NuVasive to Present at the 23rd Annual Needham Virtual Growth Conference
January 06, 2021

Summary Toggle NuVasive's X360 Procedural Approach Validated in Clinical Study Published in The Spine Journal Finding Single-Position Spine Surgery Improves Operative Efficiency While Reducing Complications and Length of Hospital Stay
January 04, 2021

Summary Toggle NuVasive to Participate in 39th Annual Virtual J.P. Morgan Healthcare Conference

Alert type
NuVasive, Inc. End-of-Day Stock Quote Alert
NuVasive, Inc. SEC Filing Alert
NuVasive, Inc. Event Alert
NuVasive, Inc. All News Alert
NuVasive, Inc. Annual Report Alert

Alert type
NuVasive, Inc. End-of-Day Stock Quote Alert
NuVasive, Inc. SEC Filing Alert
NuVasive, Inc. Event Alert
NuVasive, Inc. All News Alert
NuVasive, Inc. Annual Report Alert

NuVasive Investor Relations

Press Releases

Keyword Search

IR Contact